One-year results of the GORE EXCLUDER Conformable AAA Endoprosthesis system in the United States regulatory trial

Abstract

The safety and effectiveness of the GORE EXCLUDER Conformable AAA Endoprosthesis system has been demonstrated with 98.5% freedom from primary effectiveness end point events at 1 year and 100% freedom from primary safety end point events assessed through 30 days.